// App-Quantinova.ai

: What proportion of patients with Idiopathic Pulmonary Fibrosis fall outside UK prescribing criteria for anti-fibrotic treatment? A UK specialist centre review

Researchers

Presenter

  • Christopher J Brereton

Principal Investigators

  • Katarina Pontoppidan

  • Tim Wallis

  • Luca Richeldi

  • Mark G Jones

  • Sophie V Fletcher

Medical Centers

  • NIHR Southampton Respiratory Biomedical Res Unit, Univ Hosp Southampton, Southampton, United Kingdom

  • Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved